Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coronavirus main proteinase (Mpro/3CLpro) is an essential cysteine protease responsible for processing viral polyproteins during infection. Its unique structure-function relationship makes it central both to coronavirus biology and as a prime therapeutic target against diseases like COVID-19 due to lack of analogous human enzymes with similar specificity—enabling selective inhibition strategies with reduced risk of off-target effects.
Inhibition of Mpro blocks viral polyprotein processing, halting viral replication.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coronavirus main proteinase (Mpro).